Philip Mease
7 Podcast Episodes
Guselkumab Ranked Highest Overall in Skin Clearance with Philip Mease, MD
Guselkumab Ranked Highest Overall in Skin Clearance with Philip Mease, MD
Last week, Janssen announced results from a network meta-analysis (NMA) that showed that the biologic therapy guselkumab... Read more
31 Jan 2022
•
18mins
Rheumatology Author Prof Philip Mease: Upadacitinib in PsA
Rheumatology Author Prof Philip Mease: Upadacitinib in PsA
Professor Philip Mease from the University of Washington School of Medicine. Join Prof Peter Nash as he interviews notab... Read more
18 Jan 2021
•
24mins
Similar People
Iain McInnes
Kevin Winthrop
Stanley Cohen
William Chey
Atopic Dermatitis
Whitney Morgan
Mark Smith
Chris Buckley
George Bakris
Vibeke Strand
Carl Regillo
George Everly
Yoshiya Tanaka
Mary Rooney
Paul Emery
Discussing the guidelines for managing psoriatic arthritis: Part 2 (Dafna Gladman, Philip Mease, and Oliver FitzGerald)
Discussing the guidelines for managing psoriatic arthritis: Part 2 (Dafna Gladman, Philip Mease, and Oliver FitzGerald)
In the second of a two-part series, Dafna Gladman, Philip Mease, and Oliver FitzGerald discuss the implications and limi... Read more
11 Mar 2020
•
11mins
Researcher comment: The DISCOVER-2 trial (with Philip Mease)
Researcher comment: The DISCOVER-2 trial (with Philip Mease)
Lead investigator Philip Mease outlines the results of the DISCOVER-2 trial, and discusses how guselkumab may impact the... Read more
11 Mar 2020
•
8mins
Most Popular
Elon Musk
Barack Obama
Bill Gates
LeBron James
Mark Cuban
Michelle Obama
Melinda Gates
Arnold Schwarzenegger
Kevin Hart
Terry Crews
Mike Tyson
Discussing the guidelines for managing psoriatic arthritis: Part 1 (Dafna Gladman, Philip Mease, and Oliver FitzGerald)
Discussing the guidelines for managing psoriatic arthritis: Part 1 (Dafna Gladman, Philip Mease, and Oliver FitzGerald)
In the first of a two-part series, Dafna Gladman, Philip Mease, and Oliver FitzGerald discuss the development of the rec... Read more
30 Oct 2019
•
9mins
Researcher comment: The SPIRIT-H2H trial (with Philip Mease)
Researcher comment: The SPIRIT-H2H trial (with Philip Mease)
Lead investigator Philip Mease discusses the findings from the SPIRIT-H2H trial, a phase III head-to-head trial of ixeki... Read more
2 Jul 2019
•
7mins
Researcher comment: Tildrakizumab shows promise for PsA (with Philip Mease)
Researcher comment: Tildrakizumab shows promise for PsA (with Philip Mease)
Lead investigator Philip Mease outlines the results of a phase IIb trial supporting further development of the anti-inte... Read more
2 Jul 2019
•
8mins
